SCHEMBL2801359

SCHEMBL2801359

CCS(=O)(=O)NC(=O)c1cnn2c(Nc3ccc4c(ccn4C)c3)c(C(=O)N3CCC(c4ccccc4)CC3)cnc12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SYK P43405 1/20 0.38
DHODH Q02127 1/20 0.38
MGLL Q99685 1/20 0.37
MAPT P10636 1/20 0.36
THRB P10828 1/20 0.36
TRPC3 Q13507 1/20 0.36
TRPC6 Q9Y210 1/20 0.36
SPR P35270 1/20 0.35
FAAH O00519 1/20 0.34
RAB9A P51151 1/20 0.34
MCHR1 Q99705 1/20 0.34
ALDH1A1 P00352 1/20 0.34
FASN P49327 1/20 0.34
ACACB O00763 1/20 0.34
ACACA Q13085 1/20 0.34
TP53 P04637 1/20 0.34
F11 P03951 1/20 0.34
PDE4B Q07343 1/20 0.34
POLB P06746 1/20 0.34
STAT6 P42226 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2801711 0.90 DHODH (0.46) SYKDHODHMGLLTRPC3TRPC6
SCHEMBL2800790 0.88 KDM4E (0.39) SYKDHODHMGLLMAPTTRPC3
SCHEMBL2801661 0.87 PDE4B (0.41) MAPTTHRBTRPC3TRPC6SPR
SCHEMBL2801964 0.87 SPR (0.40) SYKMGLLTRPC3TRPC6SPR
SCHEMBL2802494 0.86 DRD2 (0.42) MAPTSPRRAB9AALDH1A1FASN
SCHEMBL2802212 0.86 SPR (0.41) SYKMGLLTRPC3TRPC6SPR
SCHEMBL2801629 0.86 MGLL (0.42) SYKMGLLSPRALDH1A1
SCHEMBL2802165 0.86 ALDH1A1 (0.38) MAPTSPRRAB9AALDH1A1FASN
SCHEMBL2831884 0.84 PDE4B (0.39) SYKDHODHMGLLMAPTTRPC3
SCHEMBL2801510 0.83 EGLN1 (0.38) SPRALDH1A1FASNF11PDE4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2206714-B1 AGENT FOR PREVENTION AND/OR TREATMENT OF SKIN DISEASES KYOWA HAKKO KIRIN CO LTD (JP) 2015-01-21 EP disclosed
US-8729264-B2 Agent for prevention and/or treatment of skin diseases KYOWA HAKKO KIRIN CO., LTD. (JP) 2014-05-20 US disclosed
US-20100256134-A1 AGENT FOR PREVENTION AND/OR TREATMENT OF SKIN DISEASES KYOWA HAKKO KIRIN CO., LTD. (JP) 2010-10-07 US disclosed
EP-2206714-A1 AGENT FOR PREVENTION AND/OR TREATMENT OF SKIN DISEASES Kyowa Hakko Kirin Co., Ltd. (JP) 2010-07-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100256134-A1 AGENT FOR PREVENTION AND/OR TREATMENT OF SKIN DISEASES TYR, CUTA, SERPINB1 SYK 958/4885DHODH 446/4885MGLL 4369/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.